Clinical trial
Low-dose Hormone Therapy for Relief of Vasomotor Symptoms
NCT00446199 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00446199 |
|---|---|
| Title | Low-dose Hormone Therapy for Relief of Vasomotor Symptoms |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Determine the Lowest Effective Dose of Combinations of Oral Drospirenone and 17 Beta-Estradiol for the Relief of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women Over a Treatment Period of 12 Weeks |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vasomotor Symptoms, Hot Flashes |
| Intervention type | Drug |
| Interventions | 0.5mg DRSP / 0.5mg E2 (BAY86-4891), 0.25mg DRSP / 0.5mg E2 (BAY86-4891), Estradiol (E2 0.3mg), Placebo |
| Enrollment | 735 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Mar 12, 2007 |
| Last update posted | May 6, 2015 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: